Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours
暂无分享,去创建一个
W. Łopuszyński | Brian Salmons | W. Günzburg | S. Winiarczyk | Ł. Adaszek | M. Michałowska | Z. Grądzki
[1] J. Hirschberger,et al. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs , 2010, Veterinary Record.
[2] S. Dow,et al. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. , 2008, Journal of veterinary internal medicine.
[3] M. Ceppi,et al. Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. , 2008, Journal of veterinary internal medicine.
[4] L. Marconato,et al. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. , 2008, Veterinary and comparative oncology.
[5] A. Wehrend,et al. Mammary tumor recurrence in bitches after regional mastectomy. , 2008, Veterinary surgery : VS.
[6] F. Schmitt,et al. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.
[7] Y. Millán,et al. A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor α and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog , 2005, Veterinary pathology.
[8] K. Sorenmo,et al. Canine mammary gland tumors. , 2003, The Veterinary clinics of North America. Small animal practice.
[9] C. Novosad. Principles of treatment for mammary gland tumors. , 2003, Clinical techniques in small animal practice.
[10] H. Bergmeister,et al. Intra-Arterial Instillation of Microencapsulated, Ifosfamide-Activating Cells in the Pig Pancreas for Chemotherapeutic Targeting , 2003, Pancreatology.
[11] Brian Salmons,et al. JMM — Past and Present , 2002, Journal of Molecular Medicine.
[12] Brian Salmons,et al. A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study. , 2002, Journal of molecular medicine.
[13] J. Ringel,et al. Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century , 2002, Cancer Chemotherapy and Pharmacology.
[14] M. Löhr,et al. Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial. , 2002, Journal of gastroenterology.
[15] G. Esposito,et al. Encapsulated cells producing retroviral vectors for in vivo gene transfer , 2002, The journal of gene medicine.
[16] L. Peña,et al. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). , 2001, Journal of the American Veterinary Medical Association.
[17] M. Löhr,et al. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma , 2001, The Lancet.
[18] T. Constantinidis,et al. Adjuvant post-operative chemotherapy in bitches with mammary cancer. , 2001, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.
[19] P. Karle,et al. Necrotic, rather than apoptotic, cell death caused by cytochrome P450–activated ifosfamide , 2001, Cancer Gene Therapy.
[20] S. Armeanu, I. Haessler, R. Saller, M. G. Engelman. In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transfer , 2001 .
[21] D. Noël,et al. Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodies. , 2000, Human gene therapy.
[22] P. Karle,et al. Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine , 2000, Cancer Gene Therapy.
[23] M. Löhr,et al. Development of Cellulose Sulfate‐based Polyelectrolyte Complex Microcapsules for Medical Applications , 1999, Annals of the New York Academy of Sciences.
[24] P. Karle,et al. Characterization of a Human Cell Clone Expressing Cytochrome P450 for Safe Use in Human Somatic Cell Therapy , 1999, Annals of the New York Academy of Sciences.
[25] H. Bergmeister,et al. Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study , 1999, Journal of Molecular Medicine.
[26] D. Noël,et al. Genetically engineered antibodies in gene transfer and gene therapy. , 1998, Human gene therapy.
[27] B. Nebe,et al. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450 , 1998, Gene Therapy.
[28] D. Waxman,et al. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. , 1996, Cancer research.
[29] G. Leclercq,et al. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs. , 1995, American journal of veterinary research.
[30] F. Abe,et al. Improvement of mitomycin C‐ and cyclophosphamide‐induced thrombocytopenia and leucocytopenia by prior treatment with deoxyspergualin in dogs , 1994, British journal of haematology.
[31] Owen Ln. A comparative study of canine and human breast cancer. , 1979 .
[32] G. Klöppel,et al. Frequency of Kras Mutations in Pancreatic Intraductal Neoplasias Associated with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis : A Meta-Analysis 1 , 2014 .
[33] Brian Salmons,et al. Therapeutic application of cell microencapsulation in cancer. , 2010, Advances in experimental medicine and biology.
[34] L. Munson,et al. Comparative pathology of mammary gland cancers in domestic and wild animals. , 2007, Breast disease.
[35] M. Löhr,et al. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. , 2005, Neoplasia.
[36] W. Uckert,et al. Combination suicide gene therapy. , 2004, Methods in molecular medicine.
[37] M. Löhr,et al. Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy. , 1998, Advances in experimental medicine and biology.
[38] A. Gordon. The increasing efficacy of breast cancer treatment. , 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).
[39] J. Stange,et al. Prolonged biochemical and morphological stability of encapsulated liver cells--a new method. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.
[40] L. Owen. A comparative study of canine and human breast cancer. , 1979, Investigative & cell pathology.